Elisabeth KrugPrincipal Research Scientist at Eli Lilly & Company
Dr. Elisabeth Krug graduated from the University of Würzburg, Germany, in 1994 as a pharmaceutical biologist. She started with Lilly in 1995 as an analytical scientist in the small molecule development. She then took an assignment in Six Sigma becoming a Master Black Belt. Since 2010, Dr. Krug has been extensively working with biomolecules, where she is responsible to support the analytical development and control strategy definition for biomolecules. Since 2020 she has been involved more deeply with the potency determination heading the bioassay development group.